Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.
Expect some changes by end of September. In my view companies will want to be bigger and better by then, by way of takeovers or mergers as Boris and co have their institutional fairs to promote uk companies or companies with a uk presence to the uk institutional investors in October. This is a lot of money at stake, at present only 20% of these type of funds are from uk.
For my part I have just added, that is my confidence. Belluscura covers potentially half our present SP in my books, Lucyd probably covers the rest. The others are pure gravy, Guident being the biggest potential. Time will tell if the decision is right or wrong. The investor selling would have bought in at 10p, not strange that they are selling. As has been mentioned, it's being mopped up. More than happy.
On the link I provided for the more geeky amongst us there are many links which give me more confidence in this investment including:
In the short term, we must be focused on the challenge at hand, so we want to hear specifically from companies who can manufacture and supply new or existing types of coronavirus tests for antigens or antibodies.
Can't wait for our well anticipated ground breaking test due to be released very soon. It's from this and any DHSC resolution which could really propell us. Sitting quietly in the background waiting for this dark horse to come in. GLA.
I would just like to add a side note to the link that I sent yesterday re DHSC procurement policy which they updated yesterday. The criteria for selling to the uk government has just got stricter. This has been brought about by poor purchasing decisions and public outcry in recent times. Basically it has been unregulated and they are finally bringing in QC. This could work in our favour, it certainly can't work against us because presently we aren't selling to DHSC. Companies which don't meet the value for money, benefit to the country AND quality of product won't have the option to tender. This will in fact decrease the competition by ignoring inferior products or manufacturers. It is clear that all previous contracts are being retrospectively looked at. As long as all was above board there is nothing to be concerned about. Stricter criteria for the bidding process I strongly welcome. There are many changes it seems about to happen in purchasing policy. Just IMO.
National technical validation process for manufacturers of SARS-CoV-2 (COVID-19) tests - GOV.UK https://www.gov.uk/government/publications/assessment-and-procurement-of-coronavirus-covid-19-tests/coronavirus-covid-19-serology-and-viral-detection-testing-uk-procurement-overview
I had been watching this company for quite a while only to finally get in at the 10p range. A few weeks ago I added, I don't normally like to average UP but I have confidence. My portfolio is heavily weighted on diagnostics, which I still have confidence in but are more of a long-term play. If they were in a better position I would have shifted a small chunk to add to Tek. My investment here is small compared to many others, only 17000 shares. This company excites me, and Guidant could be the ace in the pack. It's going to be a fun few months.
Apologies Porky, was in a less than positive mood yesterday evening. There may have been drink involved and never a good combo. I am paying the price for a very unbalanced portfolio, nobody's fault but mine. It's frustrating watching some of my smaller investments triple whilst the main investment is on the floor. Sure as hell not selling at these prices, come this far staying in for the recovery. Anyway, no excuse. Looking forward to the better days on this investment, the hard work has been done ready for the new CEO. Sales network in place. I will celebrate when it's £10 again. :)
Sorry Porky9, I will call you out on this 1 aswell. Yes it makes a difference. £10m sales in a month instead of £7m. Massive difference. Future sales of next gen of lft massive if it hits the mark. Numbers count. It's not the end of the world if 1 months numbers don't come up to expectations, but it all counts. If you want your £54 then these baby steps are important. Sorry, but you can't say that £7m a month is acceptable and still spout £54.
Kaeren, yep we no need PR. No point selling a Rolls Royce and not telling people what the benefits are. A little road show would be good, forget the jazz hands just tell them how it is. Facts not over inflated promises. RNSs only reach a select audience, time to reach out.
I may disagree on that 1 also Porky. I respect the volume we are doing, it's impressive for a company our size. Not everyone wants a Rolls Royce, if we can attract Mercedes customers aswell then more than happy. Not interested in Vauxhall customers. By dealing with DHSC we have shown how much capacity we have, we aren't filling it. We are doing well, I just believe we can do better.
Kaeren, this brings me back to a previous point. DHSC and other customers will be looking at our margins and thinking we are milking it. I would suggest in what is now a more competitive market say a 20 % price drop across the board. It doesn't necessarily mean lower profits if it means higher sales. Yes it's a gamble, but we have to move with the times and make the most out of this opportunity to finance future non covid plays. I think the results would be material. Not everyone would be on board but I believe we have got the marketing network now for 1 big push.
Porky9, sorry. I like and respect your positive outlook but once in a while even a genuine investor may voice concerns, hence it being called discussion. I can take the criticism of the company as long as it with a rational view point. If it is nothing but negative I think you can't be a real investor otherwise why are you invested? Nothing but positive I distrust just as much as the man in the street who always smiles. EVERYONE has a bad day, let the expression on your face show it. The company is trying a change of direction, or at least fresh blood for the old 1. The lack of real movement in SP to me is a sign of respect for what GM has achieved and an unknown in his replacement. Time will tell, once again it comes down to having faith in the plan.
Just by way of reference, Amryt listing on Nasdaq on 8th July 2020 resulted in 70% rise in SP in 4 months with very little new product news. Add into the equation all thats going on here, I think there will be big changes here. In my view American listing is imminent.
We are gearing up to the next phase methinks. Don't forget GM got us to where we are now. No end of thanks to him, but time for new leadership and future growth into the company we know it can be. Exciting times.
Hi. I had noticed that over the last 3 weeks. Thought nothing of it. I also noticed that on Boursorama we have a target price of 5.38 euros. Well below my target target price but above Oddos. For me there are many changes quietly happening right now.
B2HS2L, they do seem to be waiting for the right test. Wishful thinking says it's ours, you never know. Thankfully we sell widely outside of government contracts so hoping for significantly more than £100m this year. Time will tell, experience says not to put an actual number on it until it's sold and money in the bank.
We had real problems last winter, and remember we were on lockdown. No lockdown this time around and early signs of the same problems. Anybody remember BJs It will be eradicated by September speech last year? Wishful thinking is not the way to go. Still time to get on top of it with the right testing regime. Rules or no rules, I am getting away this Xmas to friends. Not sitting another year out. When half year results come out, today or by end of next week, any guidance on increased uptake on orders in the last month will give the shares a boost. Not expecting the new LFT for a few weeks in my opinion, but when it arrives.........